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In the midst of concerns for potential neurodevelopmental effects after surgical
anesthesia, there is a growing awareness that children who require sedation during
critical illness are susceptible to neurologic dysfunctions collectively termed pediatric
post-intensive care syndrome, or PICS-p. In contrast to healthy children undergoing
elective surgery, critically ill children are subject to inordinate neurologic stress
or injury and need to be considered separately. Despite recognition of PICS-p,
inconsistency in techniques and timing of post-discharge assessments continues
to be a significant barrier to understanding the specific role of sedation in later
cognitive dysfunction. Nonetheless, available pediatric studies that account for analgesia
and sedation consistently identify sedative and opioid analgesic exposures as risk
factors for both in-hospital delirium and post-discharge neurologic sequelae. Clinical
observations are supported by animal models showing neuroinflammation, increased
neuronal death, dysmyelination, and altered synaptic plasticity and neurotransmission.
Additionally, intensive care sedation also contributes to sleep disruption, an important
and overlooked variable during acute illness and post-discharge recovery. Because
analgesia and sedation are potentially modifiable, understanding the underlying
mechanisms could transform sedation strategies to improve outcomes. To move the
needle on this, prospective clinical studies would benefit from cohesion with regard
to datasets and core outcome assessments, including sleep quality. Analyses should
also account for the wide range of diagnoses, heterogeneity of this population,
and the dynamic nature of neurodevelopment in age cohorts. Much of the related
preclinical evidence has been studied in comparatively brief anesthetic exposures in
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healthy animals during infancy and is not generalizable to critically ill children. Thus,
complementary animal models that more accurately “reverse translate” critical illness
paradigms and the effect of analgesia and sedation on neuropathology and functional
outcomes are needed. This review explores the interactive role of sedatives and the
neurologic vulnerability of critically ill children as it pertains to survivorship and functional
outcomes, which is the next frontier in pediatric intensive care.
Keywords: sedative neurotoxicity, pediatric intensive care outcomes, pediatric post-intensive care syndrome,
cognitive dysfunction, delirium, opioid, benzodiazepine, neurodevelopment
INTRODUCTION
Concerns for adverse neurologic effects after surgical anesthesia
in young children prompted a Safety Communication from
the United States Food and Drug Administration in 2016
warning against the prolonged or repeated use of general
anesthesia in children under the age of 3 years and pregnant
women (United States Food and Drug Administration Safety
Communication (FDA), 2019). This warning came after several
retrospective studies reported learning disabilities and lower
standardized test scores in children who underwent elective
surgery as infants or toddlers (DiMaggio et al., 2011, 2012; Flick
et al., 2011; Block et al., 2012), and experiments of anesthesia
in young animals found increased neuronal death and abnormal
synaptic plasticity to explain this cognitive dysfunction (Sanders
et al., 2013; Jevtovic-Todorovic, 2018; Maloney et al., 2018).
More recently, however, larger prospective studies of isolated
anesthesia during infancy have not found a clear effect on
cognition, though assessments may be limited by age-appropriate
metrics in very young children (Sun et al., 2016; Warner
et al., 2018; McCann et al., 2019). Interestingly, scrutiny of
those earlier studies finds that cognitive effects were more
significantly associated with prolonged or repeated anesthesias,
or in infants with neurologic risk factors. That being the case,
while children undergoing elective surgery are generally well,
critically ill children are not healthy, and are subject to a number
of metabolic and physiologic disturbances that render them
uniquely neurologically vulnerable.
In pediatric intensive care units (PICUs) across the world,
hundreds of thousands of children are necessarily treated with
analgesics and sedatives pharmacologically similar to surgical
anesthesia for prolonged periods during the neurologic stress
of critical illness. Unlike anesthesia, which briefly overwhelms
neurotransmission to facilitate invasive surgery, intensive care
sedation alters similar neurotransmitter pathways but is titrated
over time and allows for receptor adaptation. This may be
of much greater consequence, particularly if this receptor
adaptation occurs during sensitive periods of neurodevelopment.
Pharmacologic opioids can interfere with the activity of
endogenous opioid receptors, and a number of sedatives
augment the activity of the gamma aminobutyric acid (GABA)
receptor or inhibit signaling at the N-methyl-D-aspartate
receptor (NMDAR). These receptors have important roles in
normal neurodevelopment, and there is robust evidence from
mammalian models that exogenous opioids, benzodiazepines,
propofol, and ketamine affect neurogenesis, synaptogenesis,
and myelination. Furthermore, prolonged multidrug analgesia
and sedation may induce or exacerbate cerebral effects of
critical illness such as neuroinflammation. In contrast to
the seemingly divergent laboratory and clinical evidence for
anesthetic neurotoxicity in healthy infants and toddlers, many
young children who survive critical illness are recognized to
have developmental delays and cognitive and psychological
sequelae which are collectively termed pediatric post-intensive
care syndrome (PICS-p) (Pinto et al., 2017; Manning et al.,
2018; Watson et al., 2018; Choong, 2019). While critical
illness is a complex paradigm when it comes to directly
linking causative factors to post-discharge cognitive outcomes,
multivariate analyses from adults and children consistently
identify intensive care sedation and opioid analgesia as important
and independent contributors (van Zellem et al., 2014; Watson
et al., 2019; Dervan et al., 2020a; Ely, 2020).
COGNITIVE DYSFUNCTION
Survivors of Pediatric Critical Illness or
Injury Do Not Resemble the Typical
Anesthesia Population
There is an established research literature focused on cognitive
dysfunction after surgical anesthesia; results from this body of
work should be cautiously applied to the pediatric intensive
care population if at all. While there is disparate evidence of
cognitive dysfunction after early childhood surgical anesthesia,
there is a growing body of evidence that survivors of pediatric
critical illness experience issues with cognition, particularly when
a wide range of cognitive domains are considered. Unfortunately,
many PICU outcomes studies have not prospectively collected
sedation data or performed sub-analyses of sedative and
analgesic contributions, and much is extrapolated from adult
research. Anesthetic neurotoxicity necessarily regards sedative
effects on healthy children with presumed normality in their
developing brains. Children undergoing elective anesthesia
are pre-screened for health and therefore differ considerably
from critically ill children who suffer a range of unplanned
homeostatic disruptions such as hypoperfusion, hypoxemia,
acidosis, catabolic metabolism, and inflammation. Therefore,
intensive care sedative neurotoxicity must also consider the
synergistic impact of pharmacologically similar drugs on a wide
array of neurologic stressors and injury in the developing brains
of young children.
Frontiers in Behavioral Neuroscience | www.frontiersin.org 2 August 2021 | Volume 15 | Article 713668
fnbeh-15-713668 August 10, 2021 Time: 12:24 # 3
Turner et al. Cognitive Dysfunction After Pediatric Intensive Care
As understanding of PICS-p and interest in characterizing
the long-term morbidities of PICU survivors has grown, so
has the need to advance the field of outcomes measurement
research in children (Manning et al., 2018). Although most
cognitive outcome studies to date have focused on traumatic
brain injury (TBI), congenital heart disease, and extracorporeal
membrane oxygenation (ECMO), emerging literature shows
that PICU patients who survive a wide range of diseases
not typically considered to be primarily neurologic, including
sepsis and respiratory failure, have cognitive dysfunction after
hospital discharge (Bone et al., 2014; Kachmar et al., 2018;
Williams et al., 2019). The PICS-p framework recognizes the fluid
interdependence of a child’s cognitive outcomes on their physical,
emotional, and social outcomes, and vice versa (Manning et al.,
2018). As such, concerns have been raised about the use of specific
drugs in the PICU, such as benzodiazepines and opioids, and the
dose-dependence of effects on outcomes (Dervan et al., 2020a).
van Zellem et al. (2014) reported lower overall intelligence
quotient (IQ) scores in meningococcemia survivors that received
any opioid compared to children that received sedation without
opioid. Kachmar et al.’s (2018) systematic review found that when
compared to healthy controls or normative population data,
PICU patients treated with opioids or sedatives scored worse after
discharge across the cognitive domains of attention, processing
speed, executive functioning, memory, visual motor integration,
and motor development. While a link between sedation and
cognitive outcomes was not explored in their small case series,
Elison et al. (2008) reported impairments in spatial and verbal
memory, visual processing, pattern recognition, and processing
speed in children admitted to intensive care for sepsis, sickle cell
anemia crisis, or respiratory failure. Dysfunction in any of the
aforementioned domains has the potential to yield a negative
impact on children at home, in the community, and within
learning environments.
Having a multidimensional perspective on what constitutes
cognitive outcomes is important and relevant in critical care, as
not all domains may be affected to the same degree nor recover at
the same rate. Not only is PICS-p multifaceted, but the cognitive
domain within the framework is also incredibly complex as
well. If cognition is the “process of acquiring, understanding,
and using information”, then academic performance may be a
sensitive, if not always specific, metric for cognitive dysfunction
in school aged children and teens. In a prospective multicenter
trial, Watson and Curley followed children after PICU discharge,
and found that while 6 month Pediatric Cerebral Performance
Category (PCPC) assessment of cognitive function was decreased
in only 9–15% of patients 6 months after discharge, nearly
40% of survivors self-reported impaired school functioning
on the Pediatric Quality of Life Inventory, highlighting the
importance of cognition in action. Indeed, school performance
is impacted by specific cognitive processes like those described
above (e.g., processing speed, working memory, general memory,
visual motor integration, etc.), but it is also subject to physical
issues like poorly controlled pain and sleep deprivation, as
well as issues related to mood disturbance, motivation, and
ability to pay attention. When Madderom et al. (2016) and
Schiller et al. (2016) followed cognitive outcomes in ECMO
survivors over 8 years they found that while gross measures of
intelligence were within normal ranges, these patients required
extra help in school at a higher proportion than the general
population, and specifically struggled with things such as selective
attention. PICS-p patients also commonly report feeling as
though they cannot keep up with their peers, have difficulty
focusing and paying attention, or describe their thinking as
slow or clouded. Therefore, it is important to separate testable
cognition (e.g., neuropsychological direct assessment) from
functional or social cognition (e.g., parent or teacher proxy,
academic performance) as the field moves forward in unifying the
structure and approach for assessing cognitive outcomes within
the PICS-p framework. With this distinction in mind, clinicians
and researchers should be mindful of what available outcomes
tools actually measure in the realm of pediatric cognition,
functional or adaptive skills, and development.
Limitations With Current Approach on
Measuring Cognitive Outcomes in PICU
Survivors
With the inherent complexity of cognition comes variability
on how cognitive outcomes are quantified in the research
literature. Many studies have used gross outcome evaluation
tools that broadly measure cognitive functioning while other
studies indirectly assess cognitive function via variables such as
need for academic help in school, Individualized Education Plans
(IEPs), or a learning disability diagnosis. A recent scoping review
identified 183 cognitive outcome studies using 115 different
assessment tools (Maddux et al., 2020). In this review, various
versions/revisions of the preschool and school-age versions of
the Wechsler Intelligence Scales were most commonly used
(n = 82 studies, 45%), followed by the PCPC (n = 36,
20%) and a wide array of additional measures to account
for the remaining 35%. The variation in the assessment tools
utilized to quantify cognitive outcomes likely explains some
of the differences reported across studies, as it is difficult to
compare direct measurements of cognition or intelligence with
observational reports of performance. More uniform assessments
across professional disciplines will be a crucial step forward
in drawing conclusion from this research. Fortunately, work
is underway that will leverage the findings from the scoping
review mentioned above into a recommended core outcomes
measure set (Fink et al., 2020). Even with progress in the field
at large, any single set of measures is unlikely to meet the full
need in pediatrics. As shown in Figure 1, many instruments
are limited by age group and developmental stage (i.e., many
tools are not appropriate for very young children who have not
yet developed the cognitive flexibility of executive functioning),
capacity, professional qualifications needed to administer, and a
need for validation in a PICU population.
Gross measures and/or screeners of cognitive function are
easier to administer, and often have “short form” versions
that are less time-intensive and with fewer user restrictions
than traditional neuropsychological measures. The PCPC, for
example, can be retrospectively approximated as a baseline
measurement and then compared before and after illness in
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FIGURE 1 | Continuum of Cognitive Assessments. A variety of assessment tools and approaches exist for evaluating cognitive dysfunction after discharge from
pediatric intensive care. While some are useful for surveillance or screening, they are less specific for many aspects of cognitive function, particularly cognitive
domains. Within the limitations of each strategy, investigators can select an approach that best addresses their aims. Pediatric Cerebral Performance Category
(PCPC), Functional Status Scale (FSS).
order to identify changes in cognitive status on a 6-point
scale that scores normal as a 1, moderate disability as a 3,
and vegetative state as a 5 (Fiser, 1992). While the use of
a measure like the PCPC is common (Schiller et al., 2016),
and may be appropriate for many studies seeking to capture
a general cognitive outcome variable, it does not yield specific
outcomes germane to a PICU population when cognition is a
primary outcome of interest. Similarly, seminal trials designed to
detect adverse effects of anesthesia exposure in young children
(PANDA (Sun et al., 2016), MASK (Warner et al., 2018),
and GAS (McCann et al., 2019) trials) found no difference
on overall IQ after single or multiple anesthetic exposures,
though such broad assessments with cognitive composites like
IQ may also lack the sensitivity to measure smaller but clinically
meaningful changes within specific cognitive domains (Hrabok
et al., 2014). As noted above, domains of attention, processing
speed, executive functioning, memory, visual motor integration,
motor development, verbal memory, visual processing, and
pattern recognition are previously identified areas of vulnerability
in PICU populations, with correlates to neuropathology in
mammalian models, but cognitive domains require specific
assessments often with trained professionals which may limit
availability for large research studies.
Similarly, survey data obtained from parents or teachers
are also used to approximate cognitive function, though
this methodology introduces a layer of subjectivity that may
limit interpretation. Observational reports do not directly or
objectively measure cognition, but measure observable adaptive
skills or behavior, and, as such, studies show proxy reports often
differ substantially from formal neuropsychological evaluation
of cognitive function, with outside factors confounding results
(Kurowski et al., 2013; Toplak et al., 2013). Highlighting this
point, a meta-analysis by Ing et al. (2021) included over 800
children who were prospectively enrolled in trials that collected
neurodevelopmental data after a singular anesthetic exposure
showed a 68% increased risk of reported “significant impairment”
on the Behavior Rated Inventory of Executive Function by parent
or caregiver (BRIEF, n.d.; Toplak et al., 2013) and a 47% increased
risk of significant emotional/behavioral disturbances on the
Child Behavior Checklist (CBCL; Achenbach, 2011; Achenbach
and Rescorla, 2013). However, in this same meta-analysis there
was no effect of anesthesia on formal evaluation of the Full-scale
Intelligence Quotient (FSIQ).
The collective understanding of PICS-p and interest in
characterizing the long-term cognitive morbidities of PICU
survivors is relatively new. As such, methods related to outcomes
measurement research in children, especially those focused on
cognition in PICU survivors, remain vague and in need of
refinement (Fink et al., 2020). Perhaps utilizing gross outcome
evaluation tools and/or screeners that broadly measure cognitive
functioning will yield data needed to ask the next phase questions.
However, an understanding of different cognitive domains
and how they are tested in outcomes research should be
paired with knowledge of cellular level pathophysiology of the
exposures of interest (e.g., sedatives and anesthetics) in order
to generate and test hypotheses seeking to identify modifiable
factors for improving cognitive outcomes. If we are to move
the needle in regard to modifiable factors related to sedation-
related post-PICU outcomes, it is imperative that a more
domain specific/targeted approach with the right tools at the
right time is used.
Developmental Considerations Related
to Measuring Cognitive Outcomes in
PICU Survivors
While all of the limitations on measuring cognitive outcomes
in PICU survivors discussed above are important, issues
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related to age and developmental stage are especially salient.
As noted above, children in the PICU are treated with
analgesics and sedatives for prolonged periods during the
neurologic stress of critical illness during sensitive periods of
neurodevelopment. Mammalian models show notable impact on
neurogenesis, synaptogenesis, and myelination suggesting that
younger children may be more vulnerable than older children to
the effects of analgesics and sedatives based on how brains are
built over time via the developmental process.
Timing of assessment and age are key considerations in
evaluating pediatric patients for cognitive sequelae, as a study
by Dervan et al. (2020a) of over 2,000 PICU patients identified
age less than 2 years as a risk factor for worse PCPC score
at PICU discharge. This is important given that injury to the
brain or derailments in development during infancy and early
childhood can have far reaching impacts due to this being a
foundational period in brain development. Specifically, starting
very early in development, cortical organization occurs through
the rearranging of neurons in the supporting structure of the
cortex and structural differentiation in the central nervous system
occurs (i.e., neuronal differentiation, glial cell growth, and axonal
and dendritic growth) (Volpe et al., 2017). These neurons engage
in synapse formation by sending out axons to connect with both
nearby and distant areas of the brain, setting the foundation
(and growth trajectory) for circuitry connecting far reaching
areas of the brain, which is essential for continued and normal
development of long-term cognitive function (Volpe et al., 2017).
Additionally, from birth to age 2 years, myelination and rapid
synapse formation are the most active and important processes
of cortical development (Kinney et al., 1988; Huttenlocher
and Dabholkar, 1997). This all suggests that the timing of
neurodevelopmental assessments may also be critical as survivors
of childhood critical illness may “grow into” their cognitive
deficits if foundational neurodevelopment is affected (Caprarola
et al., 2017; Sobotka et al., 2018; Choong, 2019).
Adding to the complexity of timing, assessing cognitive
outcomes in a younger population is challenging (based on the
limitations of available instrumentation), which in-turn may
contribute to an under-appreciation of the impact intensive
care sedation has on children as they age. Infant developmental
assessments are typically carried out up until 2 years of age;
however, research focused on early life assessment in vulnerable
populations suggests that this follow-up should continue at least
through preschool age, and some argue through adolescence,
to ensure that children with problems are being identified and
are receiving appropriate intervention services (van de Weijer-
Bergsma et al., 2008). The reasons for longitudinal follow-along
are twofold: (1) the pediatric brain changes overtime and (2)
the availability, reliability, and validity of tools for assessing
a wide range of cognitive abilities dramatically increases for
school aged (and beyond) populations. Pediatric survivors of
critical illness may also be left with vulnerabilities that do
not surface until significant stress is applied. Childhood and
adolescence are full of increasingly difficult academic gradations
and challenging life transitions that may unmask dysfunction at a
later time, and ensuring resilience may also be part and parcel of
improving post-intensive care outcomes. Stronger collaborations
between cognitive experts (i.e., neuropsychologists) and PICU
providers can impact early detection and support to engage
in early intervention programs and cognitive rehabilitation
services that will impact outcomes for children and their families
following childhood critical illness throughout developmental
stages and recovery.
Delirium as Prodrome
Delirium is a neurobehavioral syndrome characterized by
disrupted arousal, sleep-wake disturbances, altered sensorium,
and cognitive dysfunction. Delirium is common in the PICU,
and associated with prolonged hospitalization and increased
mortality rates (Traube et al., 2017a,b). As shown in Figure 2,
risk factors for delirium include length of stay, severity of illness,
anticholinergic burden, sleep disturbance, ICU interventions
such as mechanical ventilation, and aspects of sedation
including medication choice and depth and duration of sedation
(Turkel and Tavaré, 2003; Turkel et al., 2006). Animal models
support many of these delirium variables including impaired
cholinergic signaling, neuroinflammation, altered sleep/wake
cycles, and disrupted neurotransmission (Flacker and Lipsitz,
1999a,b; Maldonado, 2018). Opioid analgesic and GABA and
NMDA sedatives may contribute to delirium by altering
neurotransmission, disrupting sleep architecture, potentiating
neuroinflammation, inducing hyperalgesia, or inducing neuronal
and glial cell dysfunction and/or death. Given this, it is
not surprising that there are significant associations between
intensive care sedation and opioid analgesia and delirium
(Gaudreau et al., 2005).
Many risk factors for delirium are also risk factors for
morbidity and mortality in the ICU, and making distinctions
can be difficult (Wilson et al., 2020). Reality may well be
a cyclic relationship: those with greater illness or injury
severity are more susceptible to delirium given their underlying
illness and increased exposure to known risk factors, and
delirium in turn results in behavioral treatment with sedatives
that contribute to brain injury and longer duration invasive
mechanical ventilation. It is not always clear whether delirium
is a treatable transitional phenomenon between critical illness
brain stress and irreversible neurologic morbidity, but several
studies support delirium as a harbinger of post-intensive
care cognitive dysfunction (Mitchell et al., 2018). Girard
et al. (2010) and Pandharipande et al. (2013) have reported
associations between ICU delirium duration and cognitive
dysfunction at 3 and 12 months post-discharge. Likewise,
Morandi et al. (2012) not only affirmed this relationship
between length of ICU delirium and cognitive dysfunction
at 12 months post-discharge, but using magnetic resonance
imaging found an underlying loss of white matter integrity
in these patients. Interestingly, Hayhurst et al. (2020) looked
at delirium subtypes and observed a greater likelihood of
cognitive dysfunction in patients with hypoactive delirium than
hyperactive delirium. Hyperactive delirium typically garners
more attention at the bedside, as these patients can be challenging
to manage behaviorally, and thus, hypoactive delirium may
go undetected. This is of particular concern in the PICU
because hypoactive delirium appears to be more closely linked
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FIGURE 2 | Factors Contributing to Delirium and Post-Intensive Care Cognitive Dysfunction. ICU delirium is multi-factorial in nature, and is associated with
post-intensive care cognitive dysfunction. Mechanical ventilation, severity of illness, and anticholinergic burden are linked, and importantly, sedatives have been
shown to disrupt sleep/wake cycles. In animal models, sedatives and opioid analgesics have been linked to neuroinflammation and altered connectivity and
neurotransmission. Thus, treatment with sedatives and opioid analgesics has an integral role in the development of delirium and post-intensive care cognitive
dysfunction.
with post-discharge cognitive dysfunction, and young children
may have higher rates of hypoactive or mixed delirium
(Traube et al., 2017a).
SLEEPING WITH ONE EYE OPEN
Sleep Architecture Is Disrupted During
Critical Illness
Intensive care sedation directly contributes to sleep disruption
which is an additional factor leading to cognitive dysfunction
following critical illness. Sleep is an essential biological function
and, in children, it is critical for brain maturation and
development. Early childhood sleep correlates with gray and
white matter volumes particularly in the dorsolateral, prefrontal,
and hippocampal cortex (Jan et al., 2010; Kocevska et al., 2017).
Sleep disturbances during crucial periods of brain development
may impact synaptic plasticity, neuronal migration, myelination,
and memory consolidation leading to effects on cognition
(Astill et al., 2012; Spruyt, 2019). In healthy children, shorter
sleep is associated with worse cognitive function, specifically
worse school performance and executive and multiple-domain
cognitive functioning, and critically ill children are certainly
prone to disrupted sleep (Astill et al., 2012; Spruyt, 2019).
Polysomnography (PSG) in critically ill children demonstrates
severe sleep fragmentation, alterations in sleep architecture, and
circadian shifts with increased daytime sleep (Carno et al.,
2004; Al-Samsam and Cullen, 2005; Armour et al., 2011;
Kudchadkar et al., 2015). Multiple factors contribute to this sleep
disruption, including non-modifiable factors, such as metabolic
derangements of critical illness and necessary patient care
interventions. However, modifiable factors are also an issue,
including too little daytime light and orienting activity, excessive
nighttime light and noise, patient care interventions that could
safely be postponed, mode of mechanical ventilation, and the
effect of medications including sedatives (Parthasarathy and
Tobin, 2002; Al-Samsam and Cullen, 2005; Kudchadkar et al.,
2014a,b; Greenfield et al., 2020).
While both sleep and sedation are characterized by decreased
responsiveness to external stimuli, sleep and sedation are not
equivalent. As shown in Figure 3, sleep is influenced by
circadian rhythmicity and homeostatic control mechanisms and
is characterized by cyclic progression of stages: non-rapid eye
movement (NREM) [further divided into light sleep (Stages
1, 2) and deep slow wave sleep (Stages 3, 4)]; and rapid eye
movement (REM). Achieving healthy sleep stage progression
and adequate proportions of deep slow wave sleep and REM
are essential to healthy brain development, maturation, and
healing after injury. Certain associations with these vital sleep
stages are particularly salient in patients with brain injury and/or
critical illness brain stress. Slow wave sleep, measured by delta
waves on electroencephalography (EEG), is essential to waste
clearance through the glymphatic system including inflammatory
cytokines, glutamine, lactate, and damage associated proteins
(Xie et al., 2013). Slow wave sleep is also associated with
reductions in brain temperature and metabolic demand for
oxygen and glucose, as well as replenishment of ATP and
glycogen stores (Aalling et al., 2018; Caporale et al., 2021).
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FIGURE 3 | Hyponogram of Normal Sleep and Disrupted Sleep of a Sedated ICU Patient. (A) The hyponogram of normal sleep depicts the cyclic progression
through sleep stages: non-rapid eye movement [divided into light sleep (stages 1, 2) and deep slow wave sleep (stages 3, 4)] and rapid eye movement (REM) sleep.
(B) The hyponogram of a sedated intensive care unit (ICU) patient is noted to have sleep distributed during the day and night and sleep fragmentation depicted by
frequent awakenings. This patient has a predominance of light sleep (stages 1, 2) and decreased deep slow wave sleep (stages 3, 4) and REM sleep.
REM sleep deprivation decreases the threshold for cortical
spreading depressions which are found frequently after acquired
brain injuries and thought to contribute to secondary brain
injury (De Vasconcelos et al., 2004; Levesque et al., 2021).
Interestingly, a recent study of analgesia and sedation after a
variety of brain injuries found that benzodiazepine treatment
increased the incidence of cortical spreading depressions
(Hertle et al., 2012).
Intensive Care Analgesia and Sedation
Alter Sleep Cycles
Although critically ill patients receiving sedatives and analgesics
may appear asleep, PSG or EEG reveal significant fragmentation
and alteration in sleep architecture which has been more heavily
studied in adults than children (Figure 3; Armour et al., 2011;
Weinhouse and Watson, 2011). Benzodiazepines decrease both
restorative slow wave sleep and REM sleep while prolonging
stage 2 NREM (Borbély et al., 1985; Achermann and Borbély,
1987; Pandharipande and Ely, 2006; Weinhouse and Watson,
2011). Similarly, propofol significantly decreases REM sleep
(Kondili et al., 2012). Opioids also decrease slow wave and
REM sleep, and increase stage 1 NREM (Cronin et al., 2001;
Pandharipande and Ely, 2006). Dexmedetomidine, however,
appears to more closely resemble natural sleep architecture on
EEG in adults and has been shown to reduce sleep fragmentation,
though there is an apparent increase in the proportion of
stage 2 NREM sleep compared to deep slow wave and REM
sleep (Huupponen et al., 2008; Alexopoulou et al., 2014; Akeju
et al., 2016). Interestingly, a recent study by Dervan et al.
(2020b) found that critically ill children receiving primarily
combined opioid and dexmedetomidine sedation exhibited a
loss of diurnal sleep variation and spent more time in stages
1 and 2 sleep than normal for age. Moreover, this study noted
almost complete absence of REM sleep, and that sleep was so
frequently interrupted as to be fragmented into periods averaging
25 min with an interquartile range of 14–36 min. Despite the
potential for meaningful differences between adults and children,
there is sparse information regarding the specific effects of
sedative medications on sleep in the PICU, particularly in young
children who are in the midst of developmentally regulated
shifts in neurotransmitter and receptor concentrations. This must
be further elucidated in order to adjust sedative regimens to
minimize the deleterious effects on sleep. Strategies to increase
the proportion and duration of deep slow wave sleep and REM
sleep may be potential therapies to reduce secondary brain injury
and morbidity. For example, daily interruptions of continuous
sedation in adults have been shown to increase stages 3 4 NREM
and REM sleep, and thus, may be considered to improve sleep of
critically ill pediatric patients (Oto et al., 2011).
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Sleep Disturbances May Also Affect
Post-discharge Recovery
Sleep disturbances persist for many children following resolution
of critical illness. In a long-term follow up study of pediatric
critical illness, survivors suffered significantly more sleep
problems than healthy controls and 72% scored at high risk
for sleep disorders (Als et al., 2015). Patients that survive
neurocritical care with acquired brain injury are at particular
risk of deleterious effects from sleep disorders, and over half
report clinically significant sleep disturbances, many scoring
more than two standard deviations worse than healthy peers,
particularly in areas of initiation and maintenance of sleep
(Williams et al., 2020). In studies of pediatric traumatic brain
injury (TBI) survivors, sleep disturbances persist for years,
and children with worse sleep had increased emotional and
behavioral problems, including increased internalizing behaviors,
externalizing behaviors, and executive function impairments
(Beebe et al., 2007; Shay et al., 2014; Sandsmark et al., 2017;
Luther et al., 2020). In contrast to the pediatric critical care
and TBI literature, where data are incomplete for the link
between sleep disturbances and neuropsychological assessments,
there is robust data in healthy children showing a positive
association between sleep duration and cognitive performance
(Astill et al., 2012). Because critical illness by its very
nature subjects the brain to intense metabolic and physiologic
stress that may be injurious, the effect of sleep disturbances
on cognitive functioning after pediatric critical illness must be
further evaluated. Sedative use in the ICU contributes to sleep
fragmentation and altered sleep architecture, which may further
contribute to adverse cognitive outcomes; and while sedative
exposure during acute illness is often the focus, many ICU
patients require prolonged weaning from these drugs during
convalescence and recovery. Additionally, the persistence of
sleep disruption following pediatric ICU discharge should be
considered a contributing and potentially modifiable factor in
studies evaluating the link between sedatives and cognitive
outcomes in these children.
Sleep Tight, Don’t Let the Nighttime
Bathtime Bite
Given the probable detriment of sleep disturbance on neurologic
recovery after critical illness, sleep/wake patterns and sleep
hygiene during critical illness and post-discharge convalescence
are important considerations. Sleep promotion is not only
likely to be therapeutic, but characterization of abnormal sleep
architecture may add to diagnostic and/or prognostic paradigms.
Unlike adult and neonatal ICUs, sleep promotion interventions
are uncommon in many PICUs (Kudchadkar et al., 2014b).
To promote restorative sleep, strategies should be implemented
for increasing daytime natural light exposure while minimizing
light at night, reducing nighttime noise, and avoiding noxious
nocturnal patient care that could be safely postponed, such
as baths, linen changes, and scheduled x-rays. Augmenting
daytime activity, and early rehabilitation and mobility efforts
with age-appropriate schedules for sleep, therapeutic activity,
and napping can also promote circadian rhythm and sleep.
Multi-disciplinary education on the potentially deleterious effects
of analgesia and sedation on sleep is also warranted, along
with accounting for these effects during daily care decisions.
Advances are also needed in the measurement of sleep in
critically ill children. Existing research focuses on the use of
PSG and EEG to measure sleep stages and sleep disruption
which are reliable but resource intensive, and more difficult
to interpret in a critically ill population. Equipment is costly
and not only does interpretation require qualified personnel,
but delayed results limit actionable information. Moreover,
because our understanding of sleep and pediatric critical illness
is still in its infancy, specific interventions are lacking. To
advance our understanding of ICU sleep, improved techniques
for sleep monitoring are needed to promote accuracy and
accessibility on a larger scale. This is of particular importance
since routine sleep monitoring may be useful in neurologic
prognostication following critical illness, with studies showing
early return of sleep architecture to be associated with better
outcomes (Arnaldi et al., 2016). To combat sleep disruption
after PICU discharge, parental education and screening for
sleep disruption should be incorporated into discharge teaching
and follow up care for childhood critical illness survivors
(Beebe et al., 2007; Shay et al., 2014; Als et al., 2015;
Sandsmark et al., 2017; Luther et al., 2020; Williams et al.,
2020). Longitudinal studies are also warranted to objectively
study sleep cycles after critical illness to determine which
sleep disorders are most prevalent and associated with poor
outcomes, and which patients are most at risk. Finally,
interventions to improve sleep during this critical period of
recovery are needed, as no evidence based interventions currently
exist in this vulnerable population. Optimizing sleep during
critical illness and following discharge represents a potentially
modifiable target to accelerate recovery and may be crucial to
improving outcomes.
IS A BETTER MOUSE(RAT)TRAP THE
ANSWER?
Preclinical Models of Anesthetic
Neurodevelopmental Toxicity Do Not
Resemble the Typical PICU Population
Animal models have long been vital to developmental
neuroscience research due to similarities in brain maturation
that are preserved across species. Rodent models are particularly
useful because the timeline for brain development in small
mammals is compressed over the first weeks of their
comparatively abbreviated life-span (Dobbing and Sands,
1979; Rice and Barone, 2000; Semple et al., 2013). Key benefits
of preclinical models are that many variables can be controlled
for in order to answer specific mechanistic questions, and brain
tissue can be directly analyzed for pathology. Because critical
illness brain stress and injury are complex, teasing apart the
contribution of a particular factor such as sedation often requires
a model species. Moreover, if a laboratory model “reverse
translates” with enough fidelity so as to provide complementary
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cellular and molecular context to inform parallel clinical
research, expedient, actionable data can be acquired to improve
bedside practice.
To date, preclinical models of developmental sedative
neurotoxicity have largely focused on the effects of single- and
multi-drug anesthesia in healthy infant-approximate animals,
as this neurodevelopmental period includes the brain growth
spurt and the peak of synaptogenesis (Lu et al., 2006; Lunardi
et al., 2010). Reduced synaptogenesis and increased neuronal
death in animal models, in conjunction with clinical studies
focused on infants and toddlers, may have inadvertently given
the impression that only the infant and toddler brain is
vulnerable, despite potential effects on later neural refinement.
In fact, De Roo et al. (2009) and Briner et al. (2011) found
an opposite age-dependent synaptogenic increase in rodents
age-approximated to later childhood and adolescence after
identical treatments, and too many inefficient synapses can be
just as detrimental as too few. Nonetheless, the majority of
this research has been performed in rodents and non-human
primates with reproducible neuropathology and learning and
memory deficits. Notably, many drugs that are used in the
operating room are used in the PICU or are pharmacologically
similar, yet there are few if any studies of the comparatively
prolonged multi-drug exposures that occur during critical
illness. In contrast to surgical anesthesia, intensive care sedation
is administered in escalating doses for days to weeks, not
including weaning during recovery. Moreover, many PICU
patients also undergo invasive procedures under anesthesia.
PICU-typical sedation is primarily opioid-based in order to
ensure analgesia, and is commonly combined with GABA
agonist benzodiazepines (Hartman et al., 2009; Curley et al.,
2015). The alpha2 agonist sedative dexmedetomidine has seen
increasing use in the last decade despite incomplete data
regarding its effects on the developing brain (Thompson
et al., 2019; Berkenbosch, 2020). Ketamine and barbiturates are
used less frequently, and propofol is uncommon in pediatric
intensive care compared to adult ICUs (Hartman et al., 2009;
Curley et al., 2015).
Common Analgesics and Sedatives
Induce Neuropathologic Changes in the
Mammalian Brain
Pre-clinical models demonstrate increased apoptotic and
necrotic neuronal death in cell culture and infant-approximate
animals after treatment with opioids, N-methyl-D-aspartate
receptor (NMDAR) antagonists (ketamine, nitrous oxide, and
inhalational -fluranes for example), and γ-aminobutyric acid
(GABA) receptor agonists (benzodiazepines, barbiturates,
propofol, etomidate, and inhalational -fluranes) (Hu et al., 2002;
Young et al., 2005; Lu et al., 2006; Nikizad et al., 2007; Lunardi
et al., 2010; Milanovic et al., 2017; Obradovic et al., 2018).
Seminal work by Ikonomidou et al. (1989, 1999) showed that
excitatory glutamate activity at the NMDAR plays a central role in
neuronal survival, and NMDAR blockade may accelerate normal
developmental neuronal pruning. Additionally, glutamate and
GABA signaling regulate neuronal migration, axonal outgrowth,
and synaptic plasticity (McDonald and Johnston, 1990; Komuro
and Rakic, 1993; Luján et al., 2005). Opioid treatment of adult
rats reduces excitatory glutamate synapses and increases GABA
synapses in the hippocampus, as well as inhibiting glutamate
release (Nugent et al., 2007; Cai et al., 2016). Taken together,
inappropriate neuronal loss and stunted neural outgrowth and
connectivity are plausible explanations for clinically observed
cognitive dysfunction. Likewise, decreased synaptic density
or signaling in infants and toddlers would impact cognition;
and because synaptic plasticity is meant to be experiential-
based, drug-increased synapses in older children may lack
necessary integration and result in disorganized connectivity
and neurotransmission. Age younger than 2 years is a risk
factor for delirium and poor outcomes, and these age-dependent
differences between too few neurons and synapses and too many
synapses in laboratory studies may be reflected clinically in
hypoactive versus hyperactive delirium, as hypoactive delirium
appears to be more common in young children. Correlation of
synaptic pathology with early delirium assessments in animal
models would increase their translational value.
Because much of the aforementioned investigation has
been performed in prenatal or infant-approximate animals
during neurogenesis, gliogenesis, and synaptogenesis, there
is little accounting for the peak of myelination or synaptic
pruning and plasticity of later childhood. For example, Briner
and DeRoo’s anesthetic work been replicated by Xu et al.
(2019) in early childhood-approximate mice treated with
midazolam for 5 days, affirming increased synaptic density at
a time when experiential-based pruning should predominate.
This effect may be purely neuronal, but synaptic plasticity is
chaperoned by astrocytes and microglia, and drug effects in
this regard have not been adequately characterized. There is
experimental evidence for glial effects of sedatives, and additional
targeted study of PICU-typical exposures is needed as glial cells
(astrocytes, oligodendrocytes, and microglia) are not just
profoundly important to neurodevelopment, they are vital for
neurologic homeostasis and recovery, making them of particular
import to intensive care delirium and neurologic outcomes.
Inhalational anesthetics with NMDAR and GABA activity
reduce the expression of astrocytic glial fibrillary acidic protein
(GFAP) and disrupt astrocytic cytoarchitecture in culture, as
well as limit the support of axonal outgrowth by astrocytes
(Culley et al., 2013; Ryu et al., 2014). Similarly, Iqbal O’Meara
et al. (2020) noted reduced GFAP after prolonged treatment
of early-childhood approximate rats with benzodiazepine,
opioid, or combined benzodiazepine and opioid. Pertinent
to neurodevelopment and neurotransmission, GFAP anchors
glutamate transporters necessary for balancing ambient
glutamate levels to ensure sufficient regional concentrations
while preventing excitotoxic damage from excess glutamate at
the synaptic cleft (Sullivan et al., 2007). However, during periods
of excitotoxic stress, such as occur with neuroinflammation,
glutamate concentrations are increased and any drug-induced
reduction in GFAP, and thus GFAP-anchored glutamate
transporters, would have enormous impacts in exacerbating
neurologic injury. Furthermore, GFAP is an important structural
protein in astrocyte reactivity to neurologic insult and astrogliosis
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during recovery. Because intensive care exposures are prolonged
and often require weaning, it is not just the acute drug effects
that require attention, but also those during convalescence that
might impair recovery.
While benzodiazepines are most often singled out due to their
close association with clinical delirium, opioid medications are
ubiquitous in intensive care and as noted previously, also have
important neuropathologic effects. Relevant to critical illness,
which is typified by endothelial activation and inflammation,
opioids bind to microglial Toll-Like Receptor 4 (TLR-4) and
have been shown to induce neuroinflammation in a manner
similar to gram negative bacterial lipopolysaccharide (Wang
et al., 2012). This may explain the observation by van Zellem
et al.’s (2014) that children who survived meningococcemia were
more likely to score lower on IQ tests several years later if
they received any kind of opioid compared to children who
received other sedatives. Interestingly, astrocytes also express
TLR-4, and are important participants in, and modulators of,
neuroinflammation through their expression of S100 calcium-
binding protein (S100B) (Bowman et al., 2003; Van Eldik
and Wainwright, 2003; Li et al., 2020). While opioids are
typically associated with neuroinflammation through TLR4,
Iqbal O’Meara et al. (2020) found a significant increase in
cerebral S100B levels in childhood-approximate rats treated
with benzodiazepine. Exacerbated neuroinflammation may be a
key mechanism by which sedatives contribute to intensive care
neurologic morbidity, and because cholinergic signaling is anti-
inflammatory, the anticholinergic activity of some opioids and
sedatives needs to be considered as well.
In addition to modulating neuroinflammation, exogenous
opioid medications might affect endogenous opioid pathways
that are involved in myelination. This certainly impacts
neurodevelopment, but also affects myelin integrity and
remyelination during recovery. Sanchez et al. (2008);
Eschenroeder et al. (2012), and Vestal-Laborde et al. (2014)
have found dose-dependent effects of opioid medications on
developmental myelination, with lower doses accelerating
oligodendrocyte maturation and myelin compaction in prenatal
rodents, and higher doses having an opposite inhibitory effect
that involves the nociceptin/orphanin FQ receptor. Because
nociceptin is involved in pain signaling, this effect may have
broader implications for the development of hyperalgesia during
critical illness, as the Sato-Bigbee group has also reported
changes in glutamate transporters with increased nociceptin
receptor activation (Meyer et al., 2017). Interestingly, Iqbal
O’Meara et al. (2020) did not find that opioid treatment of early
childhood-approximate rats changed the expression of myelin
basic protein (MBP), but treatment with benzodiazepine did
significantly increase MBP levels. Despite evidence that PICU-
typical sedation could impact inflammation and myelin integrity
in the context of links between white matter tract abnormalities
and delirium and post-discharge cognitive dysfunction, there
remains insufficient investigation into the myelin effect of
PICU-typical sedation at a variety of ages in a variety of
disease entities. This is of particular interest because opioids are
independently associated with delirium and post-intensive care
syndrome, and they have the compounded potential to affect
neuroinflammation, synaptic plasticity and neurotransmission,
and myelin integrity.
Representative Models of PICU-Typical
Neurologic Stress and Sedation Are
Needed
It is easy to conclude from a large body of work that drug-
induced neuronal death, synaptic derangement, dysmyelination,
or altered neurotransmitter trafficking results in cognitive
dysfunction after critical illness, but this assumes that these drugs
have independent effects that are unrelated to developmental
stage and/or the surrounding physiology. To date, the bulk
of this work has been performed in healthy models with
insufficient investigation of multidrug sedation combined with
PICU-typical brain stress: ischemia, acidosis, hypoxemia, and
inflammation. Lines of investigation are also lacking into the
effects of sedatives and analgesics on the evolution of common
disease states such as TBI, stroke, cardiac arrest, and sepsis,
as well as effects on recovery from them. Brain development
is dynamic and delirium and neurologic dysfunction are
bimodal, with increased prevalence concentrated at either
end of the spectrum: immaturity of early childhood and
senescence of the geriatric adult. Importantly, while age and
illness factors cannot be changed, analgesia and sedation are
potentially modifiable, and a better understanding of the discrete
contribution of these drugs in the larger context of critical illness
is sorely needed.
As shown in Figure 4, a “reverse translational” approach
is needed in order to replicate critical illness so that more
FIGURE 4 | Proposed Experimental Paradigms for Intensive Care Sedation
and Neurologic Sequelae. Studies of sedative and analgesic use during critical
illness must account for the complex interaction between drug altered
neurotransmission and a wide variety of disease states that alter normal
neurophysiology, ranging from primary brain injury to neurologic stressors
such as hypoperfusion and inflammation. Sex and age-dependent
vulnerability must be considered, as well as a variety of phenotypes to ensure
generalizability of findings. Incorporating clinically relevant biomarkers bolsters
translational value as well.
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accurate correlations can be drawn and safer sedation strategies
can be developed. Intensive care sedation is seldom to
never achieved with a single drug, and while single drug
research is vital to understanding the role of each pathway,
the effect of drug combinations is much more relevant.
Until we have more representative models to elucidate what
happens in the brain of a septic infant treated for 2 weeks
with opioid and benzodiazepine, for example, we are left
extrapolating data from healthy animal models which may
be inaccurate or misleading. In addition, models that clarify
the mitigating or exacerbating effect of sedatives during
neurologic injury or neurocritical illness are vital; it is
improbable that any of these drugs have identical effects during
health and illness.
Delirium and PICS-p symptoms do not discriminate, and
uniformity of laboratory subjects is not translatable to the
heterogeneous PICU population. The use of exclusively male or
female animals should be discouraged, as there are important
sex effects to be considered. A variety of developmental stages
is also important, as effects may be age-dependent. For example,
the perinatal and infant brain relies on inherently active
astrocytes and microglia that may be more easily triggered into
hyperinflammatory responses, and several growth factors and
cytokines that are involved in early brain development are also
pro-inflammatory (Deverman and Patterson, 2009). Likewise,
establishing whether experimental effects are generalizable across
more than one strain of mouse or rat or outbred stock may
be informative as there are traits inherent to different strains
making them more or less favorable for one type of research
or another. Finally, the starkness of the laboratory vivarium
should be strongly considered when translating cognitive effects
from learning and memory in animals that are far removed
from the environments they evolved to function in. This
has salient implications beyond the humane care of these
animals or the risk of anthropomorphism. Human children
experience robust environmental stimuli, and non-standard
enriched vivarium housing has been shown by Konkle et al.
(2010); Connors et al. (2015), and Kentner et al. (2016)
to mitigate inflammation and improve stress response and
behavioral testing performance in animal models. This type
of effect impedes the translation of behavioral and learning
and memory data from standardly housed animals to humans
and suggests a reconsideration of animal housing to facilitate
rigorous results. Alternatively, this type of data could be used to
justify early childhood intervention or rehabilitation in survivors
of childhood critical illness. Investigators should consider the
characteristics and natural behaviors and tendencies of their
model species when evaluating cognition in order to have
clarity on what they are actually measuring (de Waal, 2017;
Genzel, 2021). Poor performance on learning and memory
tasks may be attributable to motivation, mood, or sensorimotor
deficits rather than cognition in the colloquial sense (Arakawa,
2019). On the other hand, this may be translatable to the
current challenge of directly measuring cognitive deficits in
children through full neuropsychological testing versus assessing
school performance which is impacted by functional and
social cognition.
DISCUSSION
While clinical evidence of anesthetic neurotoxicity is less
definitive than animal models would suggest, clinical studies
of neurologic dysfunction in critically ill children are far
more convincing but with a paucity of translational basic
science. In addition, while post-PICU outcome research has
blossomed in the last decade, cognitive outcome studies are
hindered by a lack of objective diagnostic criteria that are
easy to implement. Moreover, neurodevelopment is dynamic,
and evaluations need to be age-appropriate with sufficient
follow-up intervals. Isolating the mechanistic contribution of
sedatives is challenging in the complex milieu of intensive
care, yet available multivariable studies continue to single out
sedatives and opioid analgesics as risk factors. The exact
role of these medications is poorly understood whether
they are directly neurotoxic, as laboratory evidence would
suggest in healthy animals, or whether this role shifts in the
midst of hypoxemia, hypoperfusion, inflammation, acidosis,
excitotoxicity, and/or sleep deprivation. It may be that certain
drugs are more detrimental in specific disease states, and
studies helping to differentiate between patient vulnerabilities
in certain critical illnesses could help providers make more
informed choices regarding sedation and analgesia. To that
end, large scale collaboration and standardization of post-
PICU cognitive assessment is needed in order to tease out the
interactive components of this complex matrix.
There is momentum in the long-term follow-up of survivors
of childhood critical illness, and multicenter collaborations are
doing so with data-sharing in order to move the field forward:
Pediatric Outcomes Studies after PICU Investigators (POST-
PICU), Pediatric Acute Lung Injury and Sepsis Investigators
(PALISI), Pediatric Neurocritical Care Research Group
(PNCRG), the Collaborative Pediatric Critical Care Research
Network (CPCCRN), and Pediatric Intensive Care Optimizing
Long-term Outcomes (PICOLO). Members of POST-PICU and
CPCCRN recently undertook a scoping review of the post-PICU
discharge outcomes literature in order to facilitate consensus
as the specialty tackles this important problem. In order to
enroll and follow-up as many survivors as possible to accurately
gauge the scope of cognitive dysfunction, a balance needs to
be struck between ease of assessment (such as proxy metrics
that can be obtained over the phone) and the thoroughness of
a full neuropsychiatric battery. Prospective studies that account
for sedation exposure are needed, along with age-appropriate
metrics that accurately assess not only cognition, but also
factors important to functional success, such as sleep and
school performance.
Current practice shifts to improve outcomes are toward
reducing total sedative exposure, daily sedation interruptions,
increasing day/night orientation and promoting sleep, and
incorporating non-pharmacologic means such as family presence
and music to reduce stress and anxiety (Chlan et al., 2013).
Early mobility initiatives are also on the rise, and have
the benefit of increasing daytime orientation and activity
for sleep at night, reducing immobility contractures and
neuropathic pain, and possibly stimulating the production
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of protective neurotrophic factors. However, sedatives often
cannot be avoided and one drug may be better than another
in a given pathophysiology. For example, neuroinflammation
has been shown to decrease glutamate transporter density and
increase the ambient concentration of potentially excitotoxic
glutamate (Tilleux and Hermans, 2007; Takaki et al., 2012).
Partial blockade of NMDAR may therefore be beneficial, but
we do not know which patients would benefit or when in
the course of illness this would be effective. We also do
not know if this should be avoided in a particular age
group, disease state, or altogether, as NMDAR antagonists
have been shown to increase neuronal death during early
brain development in animal models. The risk/benefit ratio of
NMDAR antagonism may be entirely different during critical
illness brain stress or injury, but vital evidence for this type of
intentional use of sedative drugs is lacking from representative
animal models.
In conclusion, the impact of sedatives and analgesics in
pediatric critical illness is a burgeoning field, but one with
far-reaching implications in longitudinal recovery. Cognitive
morbidity is a particularly understudied area of PICS-p in
children, and the domain most likely impacted by sedatives
and analgesics as shown in animal models and pediatric
anesthesia literature. We need a better understanding of the
impact of prolonged and repeated exposure to neuroactive
medications on the developing brain, particularly during PICU
admission with concurrent brain injury, sleep disruption, and
neurologic stress. This will require appropriately designed
studies testing physiologically derived hypotheses with age
and domain appropriate outcome measures. This understanding
is paramount to designing meaningful interventions. We need a
translational research bridge to determine the right medication
for the right disease in the right child at the right time to ensure
the best possible recovery for our patients.
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